Sinil Pharmaceutical Co. Ltd (012790) — Free Cash Flow Generation Index
Sinil Pharmaceutical Co. Ltd (012790) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩2.41 Billion represents 1% of operating cash flow (₩2.62 Billion). Explore 012790 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinil Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Sinil Pharmaceutical Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see Sinil Pharmaceutical Co. Ltd cash flow conversion.
Annual Free Cash Flow Generation for Sinil Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Sinil Pharmaceutical Co. Ltd. Check Sinil Pharmaceutical Co. Ltd (012790) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.63x | ₩14.22 Billion | ₩22.69 Billion | ₩8.47 Billion | ▲ +325.2% |
| 2023 | 0.15x | ₩2.23 Billion | ₩15.15 Billion | ₩12.92 Billion | ▼ -53.7% |
| 2022 | 0.32x | ₩4.36 Billion | ₩13.69 Billion | ₩9.33 Billion | ▼ -52.8% |
| 2021 | 0.67x | ₩7.53 Billion | ₩11.16 Billion | ₩3.63 Billion | ▲ +188.2% |
| 2020 | 0.23x | ₩2.59 Billion | ₩11.06 Billion | ₩8.80 Billion | ▼ -66.6% |
| 2019 | 0.70x | ₩8.63 Billion | ₩12.31 Billion | ₩9.73 Billion | ▼ -63.2% |
| 2018 | 1.91x | ₩17.53 Billion | ₩9.19 Billion | ₩8.33 Billion | ▼ -8.4% |
| 2017 | 2.08x | ₩18.05 Billion | ₩8.67 Billion | ₩9.38 Billion | ▲ +71.7% |
| 2016 | 1.21x | ₩14.66 Billion | ₩12.09 Billion | ₩2.57 Billion | ▼ -24.5% |
| 2015 | 1.61x | ₩15.37 Billion | ₩9.56 Billion | ₩5.80 Billion | ▲ +29.6% |
| 2014 | 1.24x | ₩11.57 Billion | ₩9.33 Billion | ₩2.24 Billion | — |